These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8399590)

  • 1. Peritoneal macrophage and lymphocyte cytoplasmic Ca2+: effects on peritoneal immune defense mechanisms and ultrafiltration capacity in continuous ambulatory peritoneal dialysis.
    Carozzi S; Nasini MG; Pietrucci A; Santoni O; Schelotto C; Caviglia PM
    Perit Dial Int; 1993; 13 Suppl 2():S286-90. PubMed ID: 8399590
    [No Abstract]   [Full Text] [Related]  

  • 2. The peritoneal immune system and continuous ambulatory peritoneal dialysis.
    Rapoport J; Hausmann MJ; Chaimovitz C
    Nephron; 1999; 81(4):373-80. PubMed ID: 10357643
    [No Abstract]   [Full Text] [Related]  

  • 3. Lympho-monokine disorders in continuous ambulatory peritoneal dialysis.
    Carozzi S
    Contrib Nephrol; 1990; 86():128-39. PubMed ID: 2127738
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokine networks in continuous ambulatory peritoneal dialysis: interactions of resident cells during inflammation in the peritoneal cavity.
    Topley N; Mackenzie R; Jörres A; Coles GA; Davies M; Williams JD
    Perit Dial Int; 1993; 13 Suppl 2():S282-5. PubMed ID: 8399589
    [No Abstract]   [Full Text] [Related]  

  • 5. Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.
    Cameron JS
    Pediatr Nephrol; 1995 Oct; 9(5):647-62. PubMed ID: 8580033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal immune defense in continuous ambulatory peritoneal dialysis: clinical relevance and practical implications.
    Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S278-81. PubMed ID: 8399588
    [No Abstract]   [Full Text] [Related]  

  • 7. Peritoneal dialysis solution calcium concentration regulates peritoneal fibroblast proliferation in CAPD.
    Carozzi S; Nasini MG; Cantaluppi A; Salit M
    ASAIO J; 1992; 38(3):M585-8. PubMed ID: 1457927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of peripheral and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients.
    Lewis SL; Kutvirt SG; Cooper CL; Bonner PN; Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S273-7. PubMed ID: 8399587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host defense mechanisms involved in peritonitis.
    Lewis SL; Holmes CJ
    Perit Dial Int; 1993; 13 Suppl 2():S295-8. PubMed ID: 8399592
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytokine-induced peritoneal fibrosis in CAPD. Effects of Ca++ and 1,25(OH)2D3.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    ASAIO Trans; 1989; 35(3):418-20. PubMed ID: 2512968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity.
    Topley N; Williams JD
    Kidney Int Suppl; 1994 Dec; 48():S71-8. PubMed ID: 7700045
    [No Abstract]   [Full Text] [Related]  

  • 12. Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
    Liao CT; Andrews R; Wallace LE; Khan MW; Kift-Morgan A; Topley N; Fraser DJ; Taylor PR
    Kidney Int; 2017 May; 91(5):1088-1103. PubMed ID: 28065517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
    Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
    Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 ligand expression on macrophages during peritonitis in continuous ambulatory peritoneal dialysis patients.
    Yang X; Ye RG; Kong QY; Yang QQ; Gao Y; Zhong JH; Wang T
    Adv Perit Dial; 2000; 16():213-5. PubMed ID: 11045296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism.
    McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH
    Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic patterns in CAPD patients with peritonitis.
    Lamperi S; Carozzi S
    Clin Nephrol; 1988; 30 Suppl 1():S41-4. PubMed ID: 3052960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal host defense mechanisms in peritoneal dialysis.
    Holmes CJ
    Kidney Int Suppl; 1994 Dec; 48():S58-70. PubMed ID: 7700043
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between human lymphocyte antigens B8, DR3 and response to peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.
    Giacchino F; Peyretti F; Piccoli G
    Nephron; 1985; 40(4):496-7. PubMed ID: 3875046
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of Ca++ and 1,25(OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    Adv Perit Dial; 1989; 5():111-20. PubMed ID: 2577390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial peritonitis in continuous ambulatory peritoneal dialysis: effect on dialysis on host defense mechanisms.
    Findon G; Miller T
    Am J Kidney Dis; 1995 Nov; 26(5):765-73. PubMed ID: 7485129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.